Dr. Reddy’s Laboratories Ltd ADR (RDY)

Currency in USD
14.41
-0.14(-0.96%)
Closed·
Pre Market
14.67+0.26(+1.80%)
·

RDY Earnings

Latest Release
May 09, 2025
EPS / Forecast
0.22 / 0.21
Revenue / Forecast
996.00M / 961.31M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/0.213--/1.02B----Free Sign Up
03/20250.22/0.21996M/961.31M+4.76%+3.61%Free Sign Up
12/20240.197/0.21969.62M/950.54M-6.43%+2.01%Free Sign Up
09/20240.178/0.206951.11M/918.01M-13.57%+3.61%Free Sign Up
06/20241/0.95921M/874.08M+5.26%+5.37%Free Sign Up
03/20240.188/0.19848.07M/848.07M-1.26%0%Free Sign Up
12/20230.99/0.89867M/833.44M+11.24%+4.03%Free Sign Up
09/20231.07/0.88828M/815.95M+21.59%+1.48%Free Sign Up
06/20230.206/0.21822.36M/822.36M-2.1%0%Free Sign Up
03/2023-0.28/0.61767.96M/742.49M-145.9%+3.43%Free Sign Up

All numbers in USD

Dr. Reddy’s Laboratories Ltd ADR Earnings Call Summary for Q2/2025

  • Consolidated revenues up 17% YoY to INR 8,016 crores (US$957M); EBITDA at INR 2,280 crores (US$272M), up 5%
  • Acquired Nicotinell portfolio, partnered with Nestlu00e9 India; launched 22 new products in emerging markets
  • Strategic investments planned for injectables, biosimilars, and APIs; positive outlook for continued growth
  • Rituximab biosimilar to launch in Europe by Feb 2025; U.S. approval expected early FY 2026
  • GLP-1 products launch preparation underway with internal API and formulation capabilities
Last Updated: 07/11/2024, 09:24
Read Full Transcript

FAQ

What Is Dr. Reddy’s Labs ADR's Earnings Per Share (TTM)?

The Dr. Reddy’s Labs ADR EPS (TTM) is 67.88.

When Is The Next Dr. Reddy’s Labs ADR Earnings Date?

Dr. Reddy’s Labs ADR will release its next earnings report on 22 Jul 2025.

What Is Dr. Reddy’s Labs ADR’s Revenue Forecasts For Upcoming Quarters?

Dr. Reddy’s Labs ADR’s revenue forecast is 1.08B.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.